BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Emory University
NRG Oncology
Eye & ENT Hospital of Fudan University
Sun Yat-sen University
Fudan University